Search in:

Clinical Ophthalmology Volume 12, 2018 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study

Kanji Takahashi1 Department of Ophthalmology, Kansai Medical University, Osaka, Japan, [email protected]Correspondence[email protected]

Masahito Ohji2 Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan

Hiroko Terasaki3 Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Shigeru Honda4 Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan

Philippe Margaron5 Department of Ophthalmology, Novartis Pharma AG, Basel, Switzerland

Tadhg Guerin6 Department of Ophthalmology, Novartis Ireland Limited, Dublin, Ireland

Mitsuko Yuzawa7 Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan

show all

Pages 1789-1799 | Published online: 13 Sep 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Seung Wan Nam, Zeeyoon Byun, Don-Il Ham & Mingui Kong. (2022) Response to brolucizumab treatment for refractory serous pigment epithelial detachment secondary to polypoidal choroidal vasculopathy. BMC Ophthalmology 22:1.
Crossref

Satoshi Honda, Takeya Kohno, Manabu Yamamoto, Kumiko Hirayama, Akika Kyo, Michiko Hirabayashi & Shigeru Honda. (2022) Early anatomical changes and association with photodynamic therapy induced acute exudative maculopathy in patients with macular diseases. Scientific Reports 12:1.
Crossref

Jingli Guo, Xianxin Qiu, Wenyi Tang, Gezhi Xu, Michael. F. Moyers, Wei Ren, Ying Xing, Jin Gao, Jiayao Sun, Jiade Lu, Lin Kong & Wei Liu. (2021) One-Year Efficacy and Safety of Proton-Beam Irradiation Combined with Intravitreal Conbercept for Refractory or Recurrent Polypoidal Choroidal Vasculopathy: A Pilot Study. Ophthalmology and Therapy 11:1, pages 187-199.
Crossref

Mark P. Breazzano, Pedro Fernández-Avellaneda, Gerardo Ledesma-Gil, Fenghua Wang, Mark O. M. Tso & Lawrence A. Yannuzzi. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 3645 3661 .

I-Hsin Ma, Yun Hsia, Yi-Ting Hsieh, Tzyy-Chang Ho, Tso-Ting Lai, Chung-May Yang & Chang-Hao Yang. (2021) Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy. Scientific Reports 11:1.
Crossref

Franco Manzur Yarur, Victor Meza V, Rodolfo Garretón C & Aldo Muñoz Q. (2021) Addition of photodynamic therapy to anti-vascular endothelial growth factor drugs compared to anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy. Medwave 21:08, pages e8460-e8460.
Crossref

Manuel Paez-Escamilla, Mahima Jhingan, Denise S. Gallagher, Sumit Randhir Singh, Samantha Fraser-Bell & Jay Chhablani. (2021) Age-related macular degeneration masqueraders: From the obvious to the obscure. Survey of Ophthalmology 66:2, pages 153-182.
Crossref

Han Joo Cho, Kunhae Kim, Soo Hyun Lim, Dong Hyun Kang & Jong Woo Kim. (2020) Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. British Journal of Ophthalmology 104:10, pages 1443-1447.
Crossref

Yimin Wang, Mengxi Shen, Jinwei Cheng, Xiaodong Sun & Peter K. Kaiser. (2020) The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review. Journal of Ophthalmology 2020, pages 1-10.
Crossref

Mark P. Breazzano, Pedro Fernández-Avellaneda, Gerardo Ledesma-Gil, Fenghua Wang, Mark O. M. Tso & Lawrence A. Yannuzzi. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 1 17 .

Jingyuan Yang, Mingzhen Yuan, Song Xia & Youxin Chen. (2019) Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy. Journal of Ophthalmology 2019, pages 1-7.
Crossref

Jingyuan Yang, Mingzhen Yuan, Erqian Wang, Song Xia & Youxin Chen. (2019) Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study. BMC Ophthalmology 19:1.
Crossref

Raquel Goldhardt & Bradley Simon Rosen. (2019) Polypoidal Choroidal Vasculopathy. Current Ophthalmology Reports 7:1, pages 66-72.
Crossref

Sang Eun Lee, Jun Won Jang, Se Woong Kang, Kyu Hyung Park, Dong Won Lee, Jae Hui Kim & KunHo Bae. (2019) Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps. Scientific Reports 9:1.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study

Citations (14)

Articles from other publishers (14)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date